echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Study of Nervous System > JAMA subjournal: Large-scale infarction in the extended time window after stroke greatly benefits from vascular recanalization within 17.6 hours

    JAMA subjournal: Large-scale infarction in the extended time window after stroke greatly benefits from vascular recanalization within 17.6 hours

    • Last Update: 2022-11-15
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    ▎WuXi AppTec content team editor

    The New England Journal of Medicine (NEJM) has published the results of the landmark DAWN trial and DEFUSE-3 trial, confirming that patients with large-vessel occlusive ischemic stroke (LVO) use endovascular therapy (EVT), and the treatment time window can be extended to 6~24 hours, which changes the treatment mode
    of stroke.


    However, if these studies only included patients with small ischemic foci on CT perfusion imaging (CTP) or diffusion-weighted imaging (DWI), would endovascular therapy be equally effective in patients with ischaemic stroke who showed signs of massive infarction over an extended time window?


    Recently, JAMA Network Open, a sub-journal of the Journal of the American Medical Association (JAMA), published the results of the GSR-ET trial online, confirming that for ischemic stroke patients with signs of large-scale infarction within an extended time window, the vascular recanalization rate after endovascular therapy is 75%, and the patient's functional outcome is better [defined as an improved Rankin score (mRS) ≤ 3 points]


    Screenshot source: JAMA Network Open


    The study finally included 285 patients from January 2015 ~ December 2019, all of which were derived from GSR-ET (an ongoing open-label, prospective, multicenter study).

    All patients with early CT (ASPECT) score of Alberta stroke project ≤ 5 points, and received CT examination and endovascular treatment within 6~24 hours after the onset of stroke, of which 95 patients (33.
    3%) received intravenous alteplase
    .
    In 215 patients (75%) who successfully achieved recanalization after embolectomy, the mTICI was 2b/3
    .


    The results showed that 27.
    7% (79
    /285) of patients had a mRS score of ≤ 3 points
    on day 90.
    The vascular recanalization rate was 75% (215/285), which was independently related to the mRS score on day 90 ≤ 3 points (adjusted OR=4.
    39
    , 95%CI=1.
    79~10.
    72).

    The results of the inverse probability weighted analysis showed that
    if the patient's blood vessels were recanalized, the probability of mRS score ≤ 3 points on day 90 would increase by 19% (95%CI=9%~29%)
    .


    Figure 1: Endovascular recanalization is associated with mRS≤ score 3 (screenshot source: Reference [1])


    Logistic multiple regression analysis showed that for patients with ASPECT scores of 3~5 points, achieving vascular recanalization within a time window of up to 17.
    6 hours was more beneficial

    .


    Figure 2: Endovascular recanalization is associated with patient outcomes, with overlapping time windows of more than 828 minutes (screenshot source: References [1])

    A total of 33% of patients received intravenous alteplase, and current guidelines recommend alteplase when CT shows mild to moderate early ischemic changes, but not recommended for patients with large areas of low attenuation
    .
    The current score reliability for early ischaemic changes is low, and in the absence of objective thresholds, it is not clear
    how to visually distinguish early low attenuation.


    In conclusion, for patients with an ASPECT score of 3~5 and an extended time window of 17.
    6 hours, successful recanalization was beneficial
    for functional outcomes.


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.